HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosisYi‐Wen Huang, Zhihong Yang|Hepatology Communications|2023Cited by 17
PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathyZhihong Yang, Cristina Dee-Hoskins, A Zeng et al.|EP Europace|2024Cited by 1